Recent

% | $
Quotes you view appear here for quick access.

EntreMed, Inc. Message Board

  • semiequipmentgodoftheyear semiequipmentgodoftheyear Oct 29, 2006 12:34 AM Flag

    Royalty Payment $7.3 million for CY 06,

    MY GUESS, IS THE MINIMUM NUMBER!

    FROM ENMD'S 2005 REPORT:

    annual Thalomid� sales above a certain threshold. Based on the licensing agreement royalty formula, annual royalty sharing commences with Thalomid� annual sales of approximately $225 million.

    2005 Royalty Revenues $5.3 million



    CURRENT CELG RESULTS:

    Summit, New Jersey-based Celgene said sales of Thalomid, a treatment for multiple myeloma, rose 9.3 percent to $108.4 million

    THALOMID� sales for the nine-month period of 2006 were $322.8 million compared to $282.0 million in 2005, an increase of 14.5% year-over-year.

 
ENMD
1.740.00(0.00%)Jun 13 3:59 PMEDT